BioLight Life Sciences Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was ILS 2,000 compared to ILS 18,000 a year ago. Operating income was ILS 5.732 million compared to operating loss of ILS 5.103 million a year ago. Net income was ILS 8.017 million compared to net loss of ILS 4.459 million a year ago. Basic earnings per share was ILS 1.76 compared to basic loss per share of ILS 0.98 a year ago. Diluted earnings per share was ILS 1.75 compared to diluted loss per share of ILS 0.98 a year ago. Basic earnings per share from continuing operations was ILS 1.76 compared to basic loss per share from continuing operations of ILS 0.96 a year ago. Diluted earnings per share from continuing operations was ILS 1.75 compared to diluted loss per share from continuing operations of ILS 0.96 a year ago.